RNU6-1149P

Across TCGA pan-cancer cohorts, RNU6-1149P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU6-1149P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-1149P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-1149P is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

KIRC, LUAD, and UCEC are the cancer types where RNU6-1149P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-1149P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.141	.004	7	view →
LUAD	All	All	+0.211	<.001	4	view →
UCEC	All	All	+0.216	.026	2	view →
PRAD	All	All	−0.044	.044	2	view →
LIHC	Female	All	+0.139	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RNU6-1149P–KIRC

Open the KIRC breakdown →